Find Clinical Trial

Home » Find Clinical Trials » Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg. Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.

Efficacy and safety of the fixed oral low-dose perindopril arginine 3.5 mg/amlodipine 2.5 mg combination compared with each component (perindopril arginine 3.5 mg and amlodipine 2.5 mg) and with perindopril arginine 5 mg and amlodipine 5 mg. Randomized, double-blind, placebo-controlled study over 8 weeks in hypertensive patients.

← Back

Study Phase	Phase 2

Therapeutic Area	Cardiovascular Diseases

Indication	Hypertension

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	AMLODIPINE, PERINDOPRIL ARGININE, S005985

Active Substance Code	S005985

Protocol Code	CL2-05985-005

EudraCT Code	2006-005797-44

ISRCTN Code	ISRCTN14235381

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.